105 related articles for article (PubMed ID: 7248000)
1. Flux of plasma lipoproteins into human arterial intima. Comparison between grossly normal and atheromatous intima.
Nicoll A; Duffield R; Lewis B
Atherosclerosis; 1981 May; 39(2):229-42. PubMed ID: 7248000
[TBL] [Abstract][Full Text] [Related]
2. Influence of obesity on the metabolism of apolipoprotein B in humans.
Egusa G; Beltz WF; Grundy SM; Howard BV
J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
[TBL] [Abstract][Full Text] [Related]
3. Effect of a high carbohydrate diet on apoprotein-B catabolism in man.
Ginsberg HN; Le NA; Melish J; Steinberg D; Brown WV
Metabolism; 1981 Apr; 30(4):347-53. PubMed ID: 7207206
[TBL] [Abstract][Full Text] [Related]
4. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.
Beltz WF; Kesäniemi YA; Howard BV; Grundy SM
J Clin Invest; 1985 Aug; 76(2):575-85. PubMed ID: 4031063
[TBL] [Abstract][Full Text] [Related]
5. IDL, VLDL, chylomicrons and atherosclerosis.
Nordestgaard BG; Tybjaerg-Hansen A
Eur J Epidemiol; 1992 May; 8 Suppl 1():92-8. PubMed ID: 1505659
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of apolipoprotein B-containing lipoproteins in familial hypercholesterolaemia: effects of plasma exchange.
Soutar AK; Myant NB; Thompson GR
Atherosclerosis; 1979 Mar; 32(3):315-25. PubMed ID: 223591
[TBL] [Abstract][Full Text] [Related]
7. Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia.
Turner PR; Cortese C; Wootton R; Marenah C; Miller NE; Lewis B
Eur J Clin Invest; 1985 Apr; 15(2):100-12. PubMed ID: 3922766
[TBL] [Abstract][Full Text] [Related]
8. Changes in the composition of plasma lipoproteins in the chronic uremic rat.
Barry LE; Tan MH
Atherosclerosis; 1990 Dec; 85(2-3):139-50. PubMed ID: 2102077
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
Ginsberg HN; Le NA; Gibson JC
J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
[TBL] [Abstract][Full Text] [Related]
10. Catabolism of very low density lipoprotein B apoprotein in man.
Reardon MF; Fidge NH; Nestel PJ
J Clin Invest; 1978 Mar; 61(3):850-60. PubMed ID: 205554
[TBL] [Abstract][Full Text] [Related]
11. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
[TBL] [Abstract][Full Text] [Related]
12. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
14. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants.
Nordestgaard BG; Tybjaerg-Hansen A; Lewis B
Arterioscler Thromb; 1992 Jan; 12(1):6-18. PubMed ID: 1731859
[TBL] [Abstract][Full Text] [Related]
15. Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects.
Turner PR; Miller NE; Cortese C; Hazzard W; Coltart J; Lewis B
J Clin Invest; 1981 Jun; 67(6):1678-86. PubMed ID: 7240415
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
17. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
[TBL] [Abstract][Full Text] [Related]
18. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media.
Nordestgaard BG; Wootton R; Lewis B
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):534-42. PubMed ID: 7749867
[TBL] [Abstract][Full Text] [Related]
19. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain.
Nordestgaard BG; Lewis B
Atherosclerosis; 1991 Mar; 87(1):39-46. PubMed ID: 1872923
[TBL] [Abstract][Full Text] [Related]
20. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
